Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.60 |
| ▸ | WDR5 | P61964 | 4/20 | 0.60 |
| ▸ | LMNA | P02545 | 4/20 | 0.60 |
| ▸ | ENGASE | Q8NFI3 | 3/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.60 |
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
| ▸ | DDAH1 | O94760 | 2/20 | 0.60 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.60 |
| ▸ | HPGD | P15428 | 2/20 | 0.60 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.60 |
| ▸ | NPY1R | P25929 | 2/20 | 0.60 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.60 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.60 |
| ▸ | HTR3A | P46098 | 2/20 | 0.60 |
| ▸ | FASN | P49327 | 2/20 | 0.60 |
| ▸ | SARM1 | Q6SZW1 | 2/20 | 0.60 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.60 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.60 |
| ▸ | HTR1A | P08908 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Rabeprazole SCHEMBL2998947 | 1.00 | KMT2A (0.60) | KMT2ACYP2C9WDR5LMNAENGASE | |
| Rabeprazole SCHEMBL2998946 | 1.00 | KMT2A (0.60) | KMT2ACYP2C9WDR5LMNAENGASE | |
| Rabeprazole SCHEMBL491358 | 1.00 | KMT2A (0.60) | KMT2ACYP2C9WDR5LMNAENGASE | |
| Dexrabeprazole SCHEMBL22189141 | 1.00 | KMT2A (0.60) | KMT2ACYP2C9WDR5LMNAENGASE | |
| Rabeprazole SCHEMBL27964348 | 0.99 | KMT2A (0.59) | KMT2ACYP2C9WDR5LMNAENGASE | |
| Dexrabeprazole SCHEMBL30945135 | 0.99 | KMT2A (0.61) | KMT2ACYP2C9WDR5LMNAENGASE | |
| Dexrabeprazole SCHEMBL30019061 | 0.99 | KMT2A (0.61) | KMT2ACYP2C9WDR5LMNAENGASE | |
| Dexrabeprazole SCHEMBL4946138 | 0.99 | KMT2A (0.61) | KMT2ACYP2C9WDR5LMNAENGASE | |
| Rabeprazole SCHEMBL29374701 | 0.99 | KMT2A (0.61) | KMT2ACYP2C9WDR5LMNAENGASE | |
| Rabeprazole SCHEMBL23336 | 0.99 | KMT2A (0.61) | KMT2ACYP2C9WDR5LMNAENGASE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2804 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120131579-A | Enteric coated tablet containing rabeprazole sodium and application thereof | 郑州大学第一附属医院 | 2025-06-13 | — | — | CN | claimed |
| CN-118903309-A | Application of compound PIANZAIHUANG buccal tablet in preparing medicine for preventing and/or treating laryngopharyngeal reflux disease | 漳州片仔癀药业股份有限公司 | 2024-11-08 | — | — | CN | claimed |
| CN-118637597-A | Biomass-based hard carbon negative electrode material and preparation method thereof | 北京钠动新能科技有限公司 | 2024-09-13 | — | — | CN | claimed |
| CN-118311216-B | Rapid determination method for dissolution rate of sodium rabeprazole enteric-coated tablets | 湖南明瑞制药股份有限公司 | 2024-09-13 | — | — | CN | claimed |
| US-20240282425-A1 | AUTHENTICATION METHODS AND SYSTEMS FOR DISPENSED PRESCRIPTIONS | LOW GORDON KEITH (US) | 2024-08-22 | — | — | US | claimed |
| US-20240238264-A1 | INHIBITORS OF SARM1 NADASE ACTIVITY AND USES THEREOF | DISARM THERAPEUTICS, INC. | 2024-07-18 | — | — | US | claimed |
| CN-118311216-A | Rapid determination method for dissolution rate of sodium rabeprazole enteric-coated tablets | 湖南明瑞制药股份有限公司 | 2024-07-09 | — | — | CN | claimed |
| CN-118258939-A | Method for detecting levo-rabeprazole and dextro-rabeprazole in human plasma | 烟台大学 | 2024-06-28 | — | — | CN | claimed |
| WO-2024128817-A1 | NOVEL PHARMACEUTICAL COMPOSITION WITH IMPROVED STABILITY COMPRISING RABEPRAZOLE, PHARMACEUTICALLY ACCEPTABLE SALT, OR HYDRATES THEREOF | 제이더블유중외제약 주식회사 | 2024-06-20 | — | — | WO | claimed |
| US-20240189228-A1 | SUCKABLE AND/OR MELT-IN-MOUTH TABLET BASED ON HYALURONIC ACID AND CHONDROITIN SULPHATE AND SALTS THEREOF | SOFAR SWISS SA (CH) | 2024-06-13 | — | — | US | claimed |
| CN-1410062-A | Sodium rebeilazole for injection use | HUANG ZHENHUA (CN) | 2003-04-16 | — | — | CN | claimed |
| WO-2003011205-A2 | ENCAPSULATION PRODUCTS FOR CONTROLLED OR EXTENDED RELEASE | CAPRICORN PHARMA, INC. (US) | 2003-02-13 | — | — | WO | claimed |
| WO-2003011204-A2 | DRUG DELIVERY SYSTEMS | CAPRICORN PHARMA, INC. (US) | 2003-02-13 | — | — | WO | claimed |
| US-20030003151-A1 | Controlled release; drugs mixed with inert ingredients compressed into tablets | MMV FINANCIAL INC. (CA) | 2003-01-02 | — | — | US | claimed |
| WO-2002094227-A1 | CONTROLLED RELEASE DRUG DELIVERY DEVICE | SAVIT CONSULTING INC. (US) | 2002-11-28 | — | — | WO | claimed |
| US-20020044962-A1 | Encapsulation products for controlled or extended release | CHERUKURI S RAO (US) | 2002-04-18 | — | — | US | claimed |
| US-20020044960-A1 | Drug delivery systems | CAPRICORN PHARMA, INC. | 2002-04-18 | — | — | US | claimed |
| US-20020006440-A1 | Rapid-melt semi-solid compositions, methods of making same and methods of using same | CAPRICORN PHARMA, INC. | 2002-01-17 | — | — | US | claimed |
| WO-2002002081-A1 | RAPID-MELT SEMI-SOLID COMPOSITIONS, METHODS OF MAKING SAME AND METHODS OF USING SAME | CAPRICORN PHARMA, INC. (US) | 2002-01-10 | — | — | WO | claimed |
| WO-2001097753-A2 | NOVEL METHODS USING PYRIDINE DERIVATIVES | EISAI CO. LTD. (JP) | 2001-12-27 | — | — | WO | claimed |